mefruside has been researched along with Myoglobinuria in 1 studies
Mefruside: A benzene-sulfonamide-furan. It is used as a diuretic that affects the concentrating ability of the KIDNEY, increases SODIUM CHLORIDE excretion, but may not spare POTASSIUM. It inhibits CARBONIC ANHYDRASES and may increase the blood URIC ACID level.
Myoglobinuria: The presence of MYOGLOBIN in URINE usually as a result of rhabdomyolysis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shintani, S | 1 |
| Shiigai, T | 1 |
| Tsukagoshi, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Once Versus Twice Daily Electrolyte Monitoring in CHF; a Study Monitoring Electrolytes in Congestive Heart Failure Patients Being Actively Diuresed in Hospital[NCT02497742] | 96 participants (Actual) | Interventional | 2015-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for mefruside and Myoglobinuria
| Article | Year |
|---|---|
Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment.
Topics: Aged; Biopsy; Electrocardiography; Furosemide; Humans; Hypertension; Hypokalemia; Male; Mefruside; M | 1991 |